Présentation
Nearly all of the major breakthroughs in COVID-19 treatments and vaccine development have connections to ICIS members in academia, government and industry. Reflecting the diverse scientific interests in the field of cytokine biology, sessions impacting all aspects of cytokine and interferon basic science, clinical development, and medicine will update participants on these activities to reveal promising research that will lead to or has already launched cytokine-based therapeutics and immune-modifying biologics to treat COVID-19, cancer, autoimmunity, infectious disease and vaccine applications.